-
Loading metrics
Open Access
Peer-reviewed
Research Article
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
-
Tim F Cloughesy ,
Contributed equally to this work with: Tim F Cloughesy, Koji Yoshimoto, Phioanh Nghiemphu, Paul S Mischel, Ingo K Mellinghoff, Charles L Sawyers
Affiliation Department of Neurology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Koji Yoshimoto ,
Contributed equally to this work with: Tim F Cloughesy, Koji Yoshimoto, Phioanh Nghiemphu, Paul S Mischel, Ingo K Mellinghoff, Charles L Sawyers
¤ Current address: Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Affiliation Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Phioanh Nghiemphu ,
Contributed equally to this work with: Tim F Cloughesy, Koji Yoshimoto, Phioanh Nghiemphu, Paul S Mischel, Ingo K Mellinghoff, Charles L Sawyers
Affiliation Department of Neurology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Kevin Brown,
Affiliation Translational Genomics Research Institute, Phoenix, Arizona, United States of America
⨯ -
Julie Dang,
Affiliation Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Shaojun Zhu,
Affiliation Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Teli Hsueh,
Affiliation Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Yinan Chen,
Affiliation Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Wei Wang,
Affiliation Taylor Technology, Princeton, New Jersey, United States of America
⨯ -
David Youngkin,
Affiliation Translational Genomics Research Institute, Phoenix, Arizona, United States of America
⨯ -
Linda Liau,
Affiliation Department of Neurosurgery, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Neil Martin,
Affiliation Department of Neurosurgery, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Don Becker,
Affiliation Department of Neurosurgery, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Marvin Bergsneider,
Affiliation Department of Neurosurgery, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Albert Lai,
Affiliation Department of Neurology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Richard Green,
Affiliation Department of Neurology, Kaiser Permanente; Los Angeles, California, United States of America
⨯ -
Tom Oglesby,
Affiliation Taylor Technology, Princeton, New Jersey, United States of America
⨯ -
Michael Koleto,
Affiliation Taylor Technology, Princeton, New Jersey, United States of America
⨯ -
Jeff Trent,
Affiliation Translational Genomics Research Institute, Phoenix, Arizona, United States of America
⨯ -
Steve Horvath,
Affiliation Department of Biostatistics and Human Genetics, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Paul S Mischel ,
Contributed equally to this work with: Tim F Cloughesy, Koji Yoshimoto, Phioanh Nghiemphu, Paul S Mischel, Ingo K Mellinghoff, Charles L Sawyers
Affiliations Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America , Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ -
Ingo K Mellinghoff ,
Contributed equally to this work with: Tim F Cloughesy, Koji Yoshimoto, Phioanh Nghiemphu, Paul S Mischel, Ingo K Mellinghoff, Charles L Sawyers
Affiliation Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
⨯ - [ ... ],
-
Charles L Sawyers
Contributed equally to this work with: Tim F Cloughesy, Koji Yoshimoto, Phioanh Nghiemphu, Paul S Mischel, Ingo K Mellinghoff, Charles L Sawyers
*To whom correspondence should be addressed. E-mail: sawyersc@mskcc.org
Affiliation Department of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯ - [ view all ]
- [ view less ]
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
- Tim F Cloughesy,
- Koji Yoshimoto,
- Phioanh Nghiemphu,
- Kevin Brown,
- Julie Dang,
- Shaojun Zhu,
- Teli Hsueh,
- Yinan Chen,
- Wei Wang,
- David Youngkin
- Published: January 22, 2008
- https://doi.org/10.1371/journal.pmed.0050008